| Cell line name |
CUTO-3 |
|---|
| Synonyms |
CUTO3; Colorado University Thoracic Oncology-3 |
|---|
| Accession |
CVCL_C8TE |
|---|
| Resource Identification Initiative |
To cite this cell line use: CUTO-3 (RRID:CVCL_C8TE) |
|---|
| Comments |
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
|---|
| Sequence variations |
- Gene fusion; HGNC; HGNC:30321; MPRIP + HGNC; HGNC:8031; NTRK1; Name(s)=MPRIP-NTRK1; Note=MPRIP exon 21 fused to NTRK1 exon 14 (PubMed=24162815).
|
|---|
| Disease |
Lung adenocarcinoma (NCIt: C3512) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Sex of cell |
Female |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=24162815; DOI=10.1038/nm.3352; PMCID=PMC3823836
Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Severine Laure Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D. Davies, Dara L. Aisner, Amanda B. Pilling, Eamon Miles Berge ...Show all 25 authors... , Jhingook Kim, Hidefumi Sasaki, Seung-Il Park, Gregory V. Kryukov, Levi Alexander Garraway, Peter S. Hammerman, Julia Haas, Steven W. Andrews, Doron Lipson, Philip J. Stephens, Vincent A. Miller, Marileila Varella-Garcia, Pasi Antero Janne, Robert C. Doebele; Show fewer authors
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
Nat. Med. 19:1469-1472(2013) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q123030995
|
|---|
| Entry history |
|---|
| Entry creation | 05-Oct-2023 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 3 |
|---|
